Filing search / Inhibrx Biosciences, Inc. / "Death"

8-K

EX-3.2

INBX Inhibrx Biosciences, Inc.

30 May 24

Termination of a Material Definitive Agreement

4:13pm

of Directors, whether caused by resignation, death, disqualification, removal, an increase in the authorized number of directors or otherwise, may be filled

DEFM14A

INBX Inhibrx Biosciences, Inc.

26 Apr 24

Proxy related to merger

4:06pm

-109 is a precision-engineered, tetravalent death receptor 5 (DR5) agonist antibody designed to exploit the tumor-biased cell death induced by DR5

DEFA14A

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Additional proxy soliciting materials

6:38am

or qualified, or until their earlier death, disqualification, resignation or removal in accordance with the Surviving Corporation’s Organizational … and Parent. “Permitted Transfer” means a transfer of a CVR (a) upon the death of a Holder by will or intestacy; (b) by instrument to an inter vivos

8-K

EX-2.1

0uwe60 tzkivbl

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.2

y8t1b2zt yo1

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-99.1

z9617lwp

2 Nov 23

Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma

9:16am

8-K

EX-99.2

3bnmqs89trqwv23m0ll

7 Aug 23

Inhibrx Reports Second Quarter 2023 Financial Results

4:05pm

8-K

EX-99.1

2i3jzxstart1

8 May 23

Inhibrx Reports First Quarter 2023 Financial Results

4:05pm

8-K

s20q9spj8p kjmja0j

26 Apr 23

Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials

9:01am

8-K

EX-99.1

t01v3cfg1c965k67aeq

26 Apr 23

Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials

9:01am

DEFA14A

61sti1gh y6ev3zafbo

13 Apr 23

Additional proxy soliciting materials

4:06pm

8-K

EX-99.1

6mmloe 2fe34

16 Nov 22

Regulation FD Disclosure

9:01am

8-K

EX-99.2

wxzz4

16 Nov 22

Regulation FD Disclosure

9:01am